S-1/A Filing

GUIDED THERAPEUTICS INC CIK: 924515

Filing Information

Form Type	S-1/A
Accession Number	`0001654954-17-005874`
Period End Date	20170331
Filing Date	20170626
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	gthp-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 131 Income Statement 84 Cash Flow Statement 140 Stockholders Equity 31

Balance Sheet 131 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$95.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$244.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$279.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$278.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $244, $279 and $95 at March 31, 2017, December 31, 2016 and 2015, respectively	`AccountsReceivableNet`	-	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$279.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $244, $279 and $95 at March 31, 2017, December 31, 2016 and 2015, respectively	`AccountsReceivableNet`	$41.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$118.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $244, $279 and $95 at March 31, 2017, December 31, 2016 and 2015, respectively	`AccountsReceivableNet`	$190.00K	USD	Point-in-time
Inventory, net of reserves of $279, $278 and 118 at March 31, 2017 and December 31, 2016 and 2015, respectively	`InventoryNet`	$773.00K	USD	Point-in-time
Inventory, net of reserves of $279, $278 and 118 at March 31, 2017 and December 31, 2016 and 2015, respectively	`InventoryNet`	$1.12M	USD	Point-in-time
Inventory, net of reserves of $279, $278 and 118 at March 31, 2017 and December 31, 2016 and 2015, respectively	`InventoryNet`	$836.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$259.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$206.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$780.00K	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.12M	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.08M	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$318.00K	USD	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	1.60	shares	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	5.60	shares	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	1.40	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$126.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$89.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$319.00K	USD	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	1.60	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$73.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$320.00K	USD	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	1.40	shares	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	5.60	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$446.00K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$1.64K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$5.55K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$408.00K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$1.41K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$391.00K	USD	Point-in-time
Series C1 convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC1`	$0.00	USD	Point-in-time
Series C1 convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC1`	$0.00	USD	Point-in-time
Series C1 convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC1`	$0.00	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.49M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.49M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.52M	USD	Point-in-time
Series C1 convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC1`	20.30	shares	Point-in-time
Series C1 convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC1`	20.30	shares	Point-in-time
Series C1 convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC1`	20.30	shares	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$133.00K	USD	Point-in-time
Series C1 convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC1`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC1`	0.00	shares	Point-in-time
Series C1 convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC1`	4.30	shares	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$1.01M	USD	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$651.00K	USD	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$704.00K	USD	Point-in-time
Series C1 convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC1`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC1`	0.00	shares	Point-in-time
Series C1 convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC1`	4.30	shares	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$197.00K	USD	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$599.00K	USD	Point-in-time
Series C1 convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreferenceC1`	$4.31K	USD	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.35M	USD	Point-in-time
Series C1 convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreferenceC1`	$4.31K	USD	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Series C1 convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreferenceC1`	-	USD	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.36M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$686.00K	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$595.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$468.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.60M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.75M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.82M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.91M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	669.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	1,427.00	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$2.72M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$2.67M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	3.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	3.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	1,427.00	shares	Point-in-time
Deferred revenue	`DeferredRevenue`	$34.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$30.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$217.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	669.00	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.47M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$847.00K	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.42M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$2.61M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$10.54M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$8.08M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$10.76M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 1.4, 1.6 and 5.6 shares issued and outstanding as of March 31, 2017 and December 31, 2016 and 2015, (Liquidation preference of $1,406, $1,643 and $5,555 at March 31, 2017 and December 31, 2016 and 2015)	`SeriesCPreferredStock`	$514.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 1.4, 1.6 and 5.6 shares issued and outstanding as of March 31, 2017 and December 31, 2016 and 2015, (Liquidation preference of $1,406, $1,643 and $5,555 at March 31, 2017 and December 31, 2016 and 2015)	`SeriesCPreferredStock`	$2.05M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 1.4, 1.6 and 5.6 shares issued and outstanding as of March 31, 2017 and December 31, 2016 and 2015, (Liquidation preference of $1,406, $1,643 and $5,555 at March 31, 2017 and December 31, 2016 and 2015)	`SeriesCPreferredStock`	$601.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively (Liquidation preference of $4,312 at March 31, 2017 and December 31, 2016, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$701.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively (Liquidation preference of $4,312 at March 31, 2017 and December 31, 2016, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	-	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively (Liquidation preference of $4,312 at March 31, 2017 and December 31, 2016, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$701.00K	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 1,427, 669 and 3 shares issued and outstanding as of March, 31 2017, December 31, 2016 and 2015 respectively	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 1,427, 669 and 3 shares issued and outstanding as of March, 31 2017, December 31, 2016 and 2015 respectively	`CommonStockValue`	$236.00K	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 1,427, 669 and 3 shares issued and outstanding as of March, 31 2017, December 31, 2016 and 2015 respectively	`CommonStockValue`	$743.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$116.38M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$114.84M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$116.89M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-122.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.76M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-5.56M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.27M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.05M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.49M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.52M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.49M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$21.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$262.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$564.00K	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$605.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$16.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$537.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$68.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$493.00K	USD	Annual
Gross profit	`GrossProfit`	$112.00K	USD	Annual
Gross profit	`GrossProfit`	$194.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$27.00K	USD	Annual
Gross profit	`GrossProfit`	$5.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	-	USD	1 Quarter
Contract and grant revenue	`Revenues`	-	USD	Annual
Contract and grant revenue	`Revenues`	$42.00K	USD	Annual
Contract and grant revenue	`Revenues`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$91.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$733.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.48M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$290.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$82.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$117.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$393.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$718.00K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$346.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.10M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$917.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.81M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.32M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.30M	USD	Annual
Total operating expenses	`OperatingExpenses`	$3.93M	USD	Annual
Total operating expenses	`OperatingExpenses`	$519.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.82M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-6.23M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-514.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.13M	USD	1 Quarter
Other income	`OtherIncome`	$23.00K	USD	1 Quarter
Other income	`OtherIncome`	$2.00K	USD	1 Quarter
Other income	`OtherIncome`	$74.00K	USD	Annual
Other income	`OtherIncome`	$68.00K	USD	Annual
Interest expense	`InterestExpense`	$223.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.90M	USD	Annual
Interest expense	`InterestExpense`	$158.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.32M	USD	Annual
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$568.00K	USD	Annual
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$628.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$1.68M	USD	Annual
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$1.40M	USD	1 Quarter
Total other income	`OtherNonoperatingIncomeExpense`	$1.26M	USD	1 Quarter
Total other income	`OtherNonoperatingIncomeExpense`	$-150.00K	USD	Annual
Total other income	`OtherNonoperatingIncomeExpense`	$-675.00K	USD	Annual
Total other income	`OtherNonoperatingIncomeExpense`	$407.00K	USD	1 Quarter
(LOSS) INCOME FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.97M	USD	Annual
(LOSS) INCOME FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$130.00K	USD	1 Quarter
(LOSS) INCOME FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-107.00K	USD	1 Quarter
(LOSS) INCOME FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.90M	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
NET (LOSS) INCOME	`NetIncomeLoss`	$-3.97M	USD	Annual
NET (LOSS) INCOME	`NetIncomeLoss`	$-107.00K	USD	1 Quarter
NET (LOSS) INCOME	`NetIncomeLoss`	$130.00K	USD	1 Quarter
NET (LOSS) INCOME	`NetIncomeLoss`	$-6.90M	USD	Annual
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	-	USD	1 Quarter
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	-	USD	1 Quarter
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	-	USD	Annual
DEEMED DIVIDENDS	`InvestmentIncomeDividend`	$1.26M	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$470.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$99.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$1.02M	USD	Annual
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$1.34M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.00M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-340.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-206.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.50M	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-5.94K	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-24.62	USD	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	203.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	946.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	39.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.00	shares	Annual

Cash Flow Statement 140 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-3.97M	USD	Annual
Net (loss) income	`NetIncomeLoss`	$-107.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$130.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-6.90M	USD	Annual
Bad debt expense	`BadDebtExpense`	$221.00K	USD	Annual
Bad debt expense	`BadDebtExpense`	$19.00K	USD	Annual
Bad debt expense	`BadDebtExpense`	$-35.00K	USD	1 Quarter
Bad debt expense	`BadDebtExpense`	$17.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$37.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$54.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$1.22M	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$1.05M	USD	Annual
Amortization	`AdjustmentForAmortization`	-	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$54.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$1.01M	USD	Annual
Stock based compensation	`ShareBasedCompensation`	$19.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$95.00K	USD	Annual
Stock based compensation	`ShareBasedCompensation`	$30.00K	USD	1 Quarter
Non- employee stock based compensation	`NonEmployeeStockBasedCompensation`	$-400.00K	USD	Annual
Non- employee stock based compensation	`NonEmployeeStockBasedCompensation`	-	USD	Annual
Non- employee stock based compensation	`NonEmployeeStockBasedCompensation`	-	USD	1 Quarter
Non- employee stock based compensation	`NonEmployeeStockBasedCompensation`	-	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$1.40M	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$628.00K	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$1.68M	USD	Annual
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$568.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$135.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-345.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-129.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$63.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$56.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$31.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-61.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-519.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-52.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$681.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-271.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-18.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$247.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-28.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$148.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$775.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$91.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$153.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-4.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$193.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-183.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-151.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$55.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.13M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.12M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$179.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$2.17M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-1.08M	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-300.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$2.86M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.80M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-407.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-4.04M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-955.00K	USD	1 Quarter
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.00K	USD	Annual
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net proceeds from issuance of preferred stock and warrants, net	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	1 Quarter
Net proceeds from issuance of preferred stock and warrants, net	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	Annual
Net proceeds from issuance of preferred stock and warrants, net	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$3.70M	USD	Annual
Net proceeds from issuance of preferred stock and warrants, net	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	1 Quarter
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	$217.00K	USD	1 Quarter
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	-	USD	1 Quarter
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	$720.00K	USD	Annual
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	$50.00K	USD	Annual
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$377.00K	USD	Annual
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$1.96M	USD	Annual
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$1.03M	USD	1 Quarter
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$212.00K	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$143.00K	USD	Annual
Payments on notes payable	`PaymentsOfLoanCosts`	$35.00K	USD	1 Quarter
Payments on notes payable	`PaymentsOfLoanCosts`	$1.01M	USD	Annual
Payments on notes payable	`PaymentsOfLoanCosts`	$227.00K	USD	Annual
Payments on notes payable	`PaymentsOfLoanCosts`	$53.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.78M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$976.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$394.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.92M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-127.00K	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-21.00K	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-13.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$21.00K	USD	1 Quarter
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$76.00K	USD	Annual
Cash paid for Interest	`InterestPaid`	$1.00K	USD	1 Quarter
Cash paid for Interest	`InterestPaid`	-	USD	Annual
Cash paid for Interest	`InterestPaid`	$1.00K	USD	1 Quarter
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	-	USD	1 Quarter
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	$150.00K	USD	Annual
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	-	USD	1 Quarter
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	-	USD	Annual
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	-	USD	1 Quarter
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	$64.00K	USD	Annual
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	-	USD	Annual
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	-	USD	1 Quarter
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnPublicOfferingWarrants`	-	USD	Annual
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnPublicOfferingWarrants`	-	USD	1 Quarter
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnPublicOfferingWarrants`	$1.05M	USD	Annual
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnPublicOfferingWarrants`	-	USD	1 Quarter
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockaNDOfferingWarrantsResultingInTransferToEquity`	-	USD	1 Quarter
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockaNDOfferingWarrantsResultingInTransferToEquity`	$324.00K	USD	Annual
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockaNDOfferingWarrantsResultingInTransferToEquity`	-	USD	Annual
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockaNDOfferingWarrantsResultingInTransferToEquity`	-	USD	1 Quarter
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$258.00K	USD	Annual
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$17.00K	USD	1 Quarter
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$1.01M	USD	Annual
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$125.00K	USD	1 Quarter
Repayment of deferred compensation via issuance of preferred stock	`RepaymentOfDeferredCompensationViaIssuanceOfPreferredStock`	-	USD	1 Quarter
Repayment of deferred compensation via issuance of preferred stock	`RepaymentOfDeferredCompensationViaIssuanceOfPreferredStock`	-	USD	1 Quarter
Repayment of deferred compensation via issuance of preferred stock	`RepaymentOfDeferredCompensationViaIssuanceOfPreferredStock`	-	USD	Annual
Repayment of deferred compensation via issuance of preferred stock	`RepaymentOfDeferredCompensationViaIssuanceOfPreferredStock`	$100.00K	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$1.02M	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$1.34M	USD	Annual
Dividends on preferred stock	`DividendsOnPreferredStock`	$99.00K	USD	1 Quarter
Dividends on preferred stock	`DividendsOnPreferredStock`	$470.00K	USD	1 Quarter

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$-4.46M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-5.56M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-9.27M	USD	Point-in-time
Preferred dividends	`DividendsPreferredStock`	$-352.00K	USD	Annual
Preferred dividends	`DividendsPreferredStock`	$-191.00K	USD	Annual
Issuance of common stock from accrued dividends, Shares	`IssuanceOfCommonStockFromAccruedDividendsShares`	54.00	shares	Annual
Issuance of common stock from accrued dividends, Shares	`IssuanceOfCommonStockFromAccruedDividendsShares`	54.00	shares	Annual
Conversion of Series C preferred stock to common stock, Amount	`ConversionOfSeriesCPreferredStockToCommonStockAmount`	-	USD	Annual
Conversion of Series C preferred stock to common stock, Amount	`ConversionOfSeriesCPreferredStockToCommonStockAmount`	-	USD	Annual
Issuance of common stock and warrants, Amount	`IssuanceOfCommonStockAndWarrants`	$1.34M	USD	Annual
Exercise of warrants and options for common stock, Amount	`ExerciseOfWarrantsAndOptionsForCommonStockAmount`	$143.00K	USD	Annual
Conversion of debt into common stock, Amount	`DebtConversionConvertedInstrumentAmount1`	$258.00K	USD	Annual
Conversion of debt into common stock, Amount	`DebtConversionConvertedInstrumentAmount1`	$1.01M	USD	Annual
Issuance of common stock due to Series B, Tranche B warrants exchanged for shares and rights to shares, Amount	`IssuanceOfCommonStockDueToSeriesBTrancheBWarrantsExchangedForSharesAndRightsToSharesAmount`	-	USD	Annual
December 2014 public offering warrants exchange and common shares issuance, Amount	`December2014PublicOfferingWarrantsExchangeAndCommonSharesIssuanceAmount`	$322.00K	USD	Annual
Series B, Tranche A, warrant price adjustment	`SeriesBTrancheWarrantPriceAdjustment`	-	USD	Annual
Series B preferred stock exchange	`SeriesBPreferredStockExchange`	$-678.00K	USD	Annual
Series C preferred stock and warrant issuance, Amount	`SeriesCPreferredStockAndWarrantIssuanceAmount`	$3.01M	USD	Annual
Series C preferred stock exchanged for Series C1 preferred stock, Amount	`SeriesCPreferredStockExchangedForSeriesC1PreferredStockAmount`	-	USD	Annual
Issuance of common stock for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$50.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.01M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$19.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$95.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$30.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.97M	USD	Annual
Net Loss	`NetIncomeLoss`	$-107.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$130.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.90M	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$-4.46M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-5.56M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-9.27M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.